ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,622Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 78

$679K Total Retail Price of All Prescriptions

Rank: 1 out of 78

492 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in District of Columbia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 8,346 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
AMLODIPINE BESYLATE 538 426 1 2
SIMVASTATIN 525 441 2 3
LISINOPRIL 466 313 3 1
FUROSEMIDE 298 231 4 7
METOPROLOL TARTRATE 270 195 5 9
QUETIAPINE FUMARATE 257 179 6 46
DONEPEZIL HCL 216 190 7 36
HYDROCHLOROTHIAZIDE 205 178 8 4
METFORMIN HCL 181 150 9 5
LOVASTATIN 179 98 10 25
PHENYTOIN SODIUM EXTENDED 178 111 11 59
LEVOTHYROXINE SODIUM 176 122 12 15
LEVETIRACETAM 171 111 13 47
LANTUS 161 108 14 16
METOPROLOL SUCCINATE 145 130 15 12
OMEPRAZOLE 138 74 16 6
HYDRALAZINE HCL 137 110 17 48
LOSARTAN-HYDROCHLOROTHIAZIDE 130 99 18 24
TAMSULOSIN HCL 125 99 19 42
PANTOPRAZOLE SODIUM 111 101 20 63
POTASSIUM CHLORIDE 110 78 21 30
CLONIDINE HCL 108 87 22 37
NAMENDA 106 106 23 66
JANUVIA 105 72 24 58
TRAMADOL HCL 104 78 25 28
CARVEDILOL 103 53 26 23
GABAPENTIN 97 55 27 14
SERTRALINE HCL 97 81 27 27
EXELON 96 96 29 83
TRAZODONE HCL 94 58 30 55
CITALOPRAM HBR 94 65 30 72
JANTOVEN 92 64 32 74
ALLOPURINOL 92 73 32 32
CLOPIDOGREL 91 83 34 44
DIOVAN 90 88 35 29
KLOR-CON M20 88 75 36 34
VALPROIC ACID 86 32 37 89
ATENOLOL 83 63 38 10
ATORVASTATIN CALCIUM 80 75 39 8
RISPERIDONE 75 66 40 65
NEXIUM 69 40 41 38
CARBAMAZEPINE 66 59 42 92
IBUPROFEN 66 54 42 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 46 44 21
HALOPERIDOL LACTATE 64 0 45 94
MIRTAZAPINE 63 37 46 64
HYDROCODONE-ACETAMINOPHEN 62 44 S3 47 68
NOVOLOG 61 33 48 67
CIPROFLOXACIN HCL 59 46 49 99
DIOVAN HCT 59 57 49 53
GLIPIZIDE 58 40 51 19
WARFARIN SODIUM 57 54 52 102
LOSARTAN POTASSIUM 53 49 53 13
NAPROXEN 52 25 54 17
PLAVIX 52 51 54 55
CRESTOR 51 45 56 51
DILTIAZEM 24HR CD 51 48 56 81
ACTOS 51 45 56 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.